US Broker Ratings

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a 423% Potential Upside in the Biotech Sector

Anavex Life Sciences Corp. (NASDAQ: AVXL), a New York-based biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to treating neurological disorders...

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating Potential Challenges with a Promising Revenue Growth

InnovAge Holding Corp. (NASDAQ: INNV), a company firmly rooted in the healthcare sector, operates within the medical care facilities industry in the United States. With a..

Cronos Group Inc. (CRON) Stock Analysis: Navigating the Growth Potential and Challenges in the Cannabis Sector

As the cannabis industry continues to evolve, Cronos Group Inc. (NASDAQ: CRON) stands out as a key player, leveraging its presence across Canada, Israel, and other..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges with 25% Upside Potential

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is a name that resonates with potential amidst the biotechnology sector, a field known for its innovative disruptions and transformative..

Auna SA (AUNA) Stock Analysis: Potential 24% Upside in the Healthcare Sector

Auna SA (AUNA), a Luxembourg-based healthcare provider, is garnering attention from investors due to its robust potential upside. With a market cap of $428.54 million, Auna..

Xencor, Inc. (XNCR) Stock Analysis: A Biotech Gem with 137.90% Potential Upside

Xencor, Inc. (NASDAQ: XNCR) is capturing the attention of investors seeking opportunities within the healthcare sector, particularly in the biotechnology industry. With a market capitalization of..

Sonida Senior Living, Inc. (SNDA): Performance Highlights Amidst Navigating Challenges in the Healthcare Sector

Sonida Senior Living, Inc. (SNDA) stands as a significant player in the United States’ senior housing sector, offering a range of specialized services from independent and..

Eton Pharmaceuticals, Inc. (ETON) Stock Report: Exploring a Promising 49.25% Potential Upside

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a burgeoning player in the healthcare sector focusing on rare diseases, is capturing investor attention with its impressive growth trajectory and..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A Biotech Gem with Over 100% Upside Potential

Investors with an eye on the healthcare sector, particularly in biotechnology, may want to pay close attention to Trevi Therapeutics, Inc. (NASDAQ: TRVI). This promising clinical-stage..

Oculis Holding AG (OCS) Stock Analysis: Unveiling an 86.86% Potential Upside in the Biotech Sector

For investors with an eye on the healthcare sector, Oculis Holding AG (OCS) presents a compelling opportunity, particularly given its position within the burgeoning biotechnology industry...

Castle Biosciences, Inc. (CSTL) Stock Analysis: Uncovering an 88% Potential Upside in Molecular Diagnostics

Castle Biosciences, Inc. (NASDAQ: CSTL), a prominent player in the molecular diagnostics field, is capturing investor interest with its innovative diagnostic solutions and significant potential upside...

REGENXBIO Inc. (RGNX) Stock Analysis: A Biotech Gem with 232.75% Upside Potential

Navigating the dynamic landscape of biotechnology, REGENXBIO Inc. (NASDAQ: RGNX) stands out as a clinical-stage company with a promising gene therapy portfolio. With a market capitalization..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating the Healthcare Sector with a 20% Potential Upside

Community Health Systems, Inc. (NYSE: CYH) presents an intriguing case for investors interested in the healthcare sector, especially those eyeing potential gains of up to 20%..

OrthoPediatrics Corp. (KIDS) Stock Analysis: A Look at Its 50% Potential Upside

OrthoPediatrics Corp. (NASDAQ: KIDS), a prominent player in the medical devices industry with a focus on pediatric orthopedic solutions, has recently garnered significant attention from investors...

Evolus, Inc. (EOLS) Stock Analysis: Unpacking a Potential 201.78% Upside for Investors

Evolus, Inc. (NASDAQ: EOLS), a key player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, presents a compelling case for investors..

Theravance Biopharma, Inc. (TBPH): Investor Outlook Reveals 13% Potential Upside Amid Strategic Biotech Ventures

Theravance Biopharma, Inc. (NASDAQ: TBPH) is a noteworthy player in the biotechnology sector, capturing investor attention with its compelling growth prospects and strategic collaborations. Based in..

Syndax Pharmaceuticals (SNDX) Investor Outlook: Exploring a 63% Potential Upside in the Biotech Arena

For investors with an eye on the biotechnology sector, Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) presents a compelling opportunity, underscored by a potential upside of 63.26%. With..

Neuropace, Inc. (NPCE) Investor Outlook: Exploring a 51.37% Potential Upside in the Medical Device Sector

Neuropace, Inc. (NASDAQ: NPCE), a promising player in the healthcare sector, particularly in the medical device industry, is capturing the attention of investors with its innovative..

LifeMD, Inc. (LFMD) Stock Analysis: Examining a 141% Potential Upside in the Healthcare Sector

LifeMD, Inc. (NASDAQ: LFMD) stands out in the healthcare sector with its direct-to-patient telehealth services, offering a promising yet complex investment opportunity. Based in New York,..

Claritev Corporation (CTEV) Stock Analysis: Potential 178.68% Upside Captivates Investor Interest

Claritev Corporation (NASDAQ: CTEV), a key player in the health information services industry, is capturing investor attention with a striking potential upside of 178.68%. The company..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds